有価証券レコード · アーカイブ済み四半期
VRDN
Viridian Therapeutics, Inc. · Healthcare · Biotechnology
16追跡対象保有者
-1Δ保有者数
34.97M保有株数
$754.70M報告済み評価額
+0新規ポジション
−1解消銘柄
モメンタム指標（同類マネージャー）：
保有者の広がり -5.9% ·
株式フロー -0.1% ·
新規ネットポジション数 -6.2%
— 計算式
幅広い売り распределение — 株式数の減少と保有者数の縮小
すべての保有状況データ：追跡対象13Fマネージャーのみ、普通株ポジション、報告期間 Q3 2025
保有状況の推移
| 四半期 | 保有者 | Δ | 株数 | 報告済み評価額 | 新規 | 解消銘柄 |
|---|---|---|---|---|---|---|
| Q2 2026 | 73 | -12 | 71.65M | $1.32B | +6 | −18 |
| Q1 2026 | 88 | +7 | 66.96M | $1.32B | +11 | −5 |
| Q4 2025 | 82 | +2 | 62.58M | $1.95B | +4 | −1 |
| Q3 2025 | 16 | -1 | 34.97M | $754.70M | — | −1 |
| Q2 2025 | 14 | -2 | 33.44M | $467.46M | — | −2 |
| Q1 2025 | 13 | +2 | 10.47M | $141.20M | +2 | — |
| Q4 2024 | 11 | -2 | 10.88M | $208.63M | — | −2 |
| Q3 2024 | 12 | +3 | 5.78M | $131.57M | +3 | — |
| Q2 2024 | 9 | — | 3.15M | $40.97M | — | — |
保有者情報 · Q3 2025
| # | 運用会社 | 株数 | Δ株式数 | 時価 | そのウェイト | 保有中 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 12.25M | +0.1% | $264.34M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 12.25M | +0.1% | $264.34M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 12.25M | +0.1% | $264.34M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (パッシブ) | 5.43M | -1.7% | $117.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (パッシブ) | 5.43M | -1.7% | $117.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (パッシブ) | 5.43M | -1.7% | $117.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (パッシブ) | 5.43M | -1.7% | $117.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (パッシブ) | 5.43M | -1.7% | $117.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (パッシブ) | 5.43M | -1.7% | $117.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (パッシブ) | 5.43M | -1.7% | $117.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | BlackRock ✦ (パッシブ) | 5.43M | -1.7% | $117.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | BlackRock ✦ (パッシブ) | 5.43M | -1.7% | $117.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | BlackRock ✦ (パッシブ) | 5.43M | -1.7% | $117.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | BlackRock ✦ (パッシブ) | 5.43M | -1.7% | $117.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | BlackRock ✦ (パッシブ) | 5.43M | -1.7% | $117.15M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | The Vanguard Group ✦ (パッシブ) | 4.33M | -3.9% | $93.48M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | The Vanguard Group ✦ (パッシブ) | 4.33M | -3.9% | $93.48M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | The Vanguard Group ✦ (パッシブ) | 4.33M | -3.9% | $93.48M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | The Vanguard Group ✦ (パッシブ) | 4.33M | -3.9% | $93.48M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | The Vanguard Group ✦ (パッシブ) | 4.33M | -3.9% | $93.48M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | State Street Global Advisors ✦ (パッシブ) | 2.55M | 0.0% | $55.12M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 22 | T. Rowe Price ✦ | 2.42M | -16.5% | $52.18M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 23 | T. Rowe Price ✦ | 2.42M | -16.5% | $52.18M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 24 | Geode Capital Management ✦ (パッシブ) | 1.77M | +1.5% | $38.12M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 25 | Geode Capital Management ✦ (パッシブ) | 1.77M | +1.5% | $38.12M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 26 | Adage Capital Partners ✦ | 1.22M | +10.1% | $26.33M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | Fisher Asset Management ✦ | 1.20M | +135.6% | $25.92M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 28 | Wellington Management ✦ | 1.12M | +314.9% | $24.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 29 | Wellington Management ✦ | 1.12M | +314.9% | $24.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 30 | Wellington Management ✦ | 1.12M | +314.9% | $24.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 31 | Wellington Management ✦ | 1.12M | +314.9% | $24.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 32 | Wellington Management ✦ | 1.12M | +314.9% | $24.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 33 | Wellington Management ✦ | 1.12M | +314.9% | $24.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 34 | Wellington Management ✦ | 1.12M | +314.9% | $24.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 35 | Marshall Wace ✦ | 869.19K | -28.0% | $18.76M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 36 | Goldman Sachs Group ✦ | 764.56K | — | $16.50M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Goldman Sachs Group ✦ | 764.56K | — | $16.50M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 618.27K | — | $13.34M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 618.27K | — | $13.34M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 618.27K | — | $13.34M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 618.27K | — | $13.34M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 618.27K | — | $13.34M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 618.27K | — | $13.34M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Morgan Stanley ✦ | 191.94K | — | $4.14M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Morgan Stanley ✦ | 191.94K | — | $4.14M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Morgan Stanley ✦ | 191.94K | — | $4.14M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Morgan Stanley ✦ | 191.94K | — | $4.14M | 0.0% | n/c | 1 | SEC ↗ |
| 48 | Morgan Stanley ✦ | 191.94K | — | $4.14M | 0.0% | n/c | 1 | SEC ↗ |
| 49 | Morgan Stanley ✦ | 191.94K | — | $4.14M | 0.0% | n/c | 1 | SEC ↗ |
| 50 | Morgan Stanley ✦ | 191.94K | — | $4.14M | 0.0% | n/c | 1 | SEC ↗ |
| 51 | Millennium Management ✦ | 136.28K | +129.3% | $2.94M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 52 | Citadel Advisors ✦ | 77.37K | -88.1% | $1.67M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 53 | Two Sigma Investments ✦ | 22.01K | -68.5% | $474,997 | 0.0% | ▼ Trim | 6 | SEC ↗ |
「当該ウェイト」= そのマネージャーの報告済み13F株式評価額に占めるポジションの割合（確信度の指標）。✦ = キュレーション済みマネージャー。
新規買い手
| 今四半期は新規追跡買い手がいません。 |
ポジション解消済み
| Point72 Asset Management | $1.45M | だった 0.0% |
市場全体のコンテキスト: 全13Fファイラー対象（SEC構造化データ、 Q1 2026): 225 保有者, 111.32M 株式数, $2.12B 報告済み. これは上記の追跡対象ユニバースの数値とは異なる、より古い期間のものであり、両者が混在することはありません。
共同保有が多い銘柄
この有価証券の追跡対象保有者が最も頻繁に保有する他の銘柄 — ファンダメンタルな関係ではなく、共同保有件数に基づきます。
市場内買い付け (P)
カバレッジ期間内にインサイダーによる市場内買い付けはありません。
市場内売却 (S)
Aug 19
Tousignant Jennifer
Officer · 4.21K 株 · $103,194
Aug 19
Tousignant Jennifer
Officer · 10.00K 株 · $245,000
株式付与、権利行使および税務目的の株式差し引きは、買いや売りとして集計しません。 方法論
Aug 20
SC 13G — Point72 Asset Management, L.P.
Aug 14
SC 13G/A — Paradigm Biocapital Advisors LP
Aug 14
SC 13G/A — Kynam Capital Management, LP
Aug 14
SC 13G/A — Deep Track Capital, LP
Aug 14
SC 13G — PRICE T ROWE ASSOCIATES INC /MD/
Aug 07
SC 13G — STATE STREET CORP
Jun 26
SC 13G — Paradigm Biocapital Advisors LP